Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Experimental Hematology & Oncology|June 1, 2017
Clinical implications of c-maf expression in plasma cells from patients with multiple myelomaGuoQing Wei, LiJun Wang, HanJin Yang, et al.
ACS Sensors|April 23, 2025
Programmable and Spatial Stiffness Gradient Substrates for Highly Robust Artificial SkinsQibin Zhuang, Yiyi Zhang, Lianjie Lu, et al.
Nano-Micro Letters|January 4, 2026
Flexible Sensors for Battery Health MonitoringXin Wang, Haiyan Zhang, Xinyi Qi, et al.
Protein & Cell|February 15, 2018
Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathwayLi Yang, Jing Chen, Xiaoyan Han, et al.
The American Journal of the Medical Sciences|September 19, 2012
A retrospective analysis of cytogenetic and clinical characteristics in patients with multiple myelomaJingsong He, Li Yang, Xiaojian Meng, et al.
Therapeutic Advances in Medical Oncology|August 27, 2025
Dialysis dependence is associated with poor prognosis in multiple myeloma: a multicenter retrospective cohort studyJi-Nuo Wang, Chenyun Wang, Jinping Ying, et al.
Cancer Letters|January 21, 2019
Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expressionHaimeng Yan, Mengmeng Dong, Xinling Liu, et al.
Plos One|June 12, 2014
The choice of regimens based on bortezomib for patients with newly diagnosed multiple myelomaJingsong He, Li Yang, Xiaoyan Han, et al.
Blood Advances|October 29, 2025
Long term Follow-up of Zevor-cel in Patients with Relapsed/Refractory Multiple MyelomaChengcheng Fu, Wenming Chen, Zhen Cai, et al.
Hematology (Amsterdam, Netherlands)|October 7, 2024
When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional studyXincheng Jiang, Xiaoyan Han, Fengyan Jin, et al.
Pageof 11